N2C Derm & Pain LP — Form D

N2C Derm & Pain LP of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2019-04-04. $42.1M was reported sold. Industry: Pooled Investment Fund.

Offering

Filed: 2019-04-04
Form: D
Accession: 0001771266-19-000001
Industry: Pooled Investment Fund
Exemptions: 06b,3C,3C.7
Amount sold: $42.1M
Investors: 3
Security types: fund interests
Revenue range: Decline to Disclose
SEC file number: 021-336417

Issuer

Name: N2C Derm & Pain LP
CIK: 0001771266
Entity type: Limited Partnership
Jurisdiction: DELAWARE
Incorporated: 2019
Address: 747 3RD AVENUE, SUITE 2101, NEW YORK, NY, 10017
Phone: 212-913-9983

Officers, directors & promoters (8)

Name	Role	Location
JORDAN BRADLEY	Related Person	NEW YORK, NY
CLAY COLE	Related Person	NEW YORK, NY
TJARKO HEKTOR	Related Person	NEW YORK, NY
DAN TOWNSEND	Related Person	NEW YORK, NY
TJARKO HEKTOR	Executive Officer	NEW YORK, NY
CLAY COLE	Executive Officer	NEW YORK, NY
DAN TOWNSEND	Executive Officer	NEW YORK, NY
JORDAN BRADLEY	Executive Officer	NEW YORK, NY

More